CN Patent

CN108066303A — 一种抗癌药物组合物及其制备方法

Assigned to Hunan Bo Jun Bio Medicine Co Ltd · Expires 2018-05-25 · 8y expired

What this patent protects

本发明涉及药物制剂领域，具体公开了一种抗癌药物组合物及其制备方法。本发明所述的药物组合物包括以下质量百分含量的组分：帕布昔利布26％‑30％，麦芽糖醇30％‑36％，预胶化淀粉30％‑40％，海藻酸钠1％‑3％，甲基纤维素1％‑3％。该组合物适合湿法制粒，其采用湿法制粒制得的片剂溶出度高、杂质含量低、流动性好、片重差异小、稳定性好。

USPTO Abstract

本发明涉及药物制剂领域，具体公开了一种抗癌药物组合物及其制备方法。本发明所述的药物组合物包括以下质量百分含量的组分：帕布昔利布26％‑30％，麦芽糖醇30％‑36％，预胶化淀粉30％‑40％，海藻酸钠1％‑3％，甲基纤维素1％‑3％。该组合物适合湿法制粒，其采用湿法制粒制得的片剂溶出度高、杂质含量低、流动性好、片重差异小、稳定性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN108066303A
Jurisdiction
CN
Classification
—
Expires
2018-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Bo Jun Bio Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.